We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
Better Home & Finance Holding
BETR
$204M
| $4.86M | ﹤0.01% |
392,529
+30,284
| +8% | +$393K |
2023 Q4
6 quarters
|
|
3227
Achieve Life Sciences
ACHV
$719M
| $4.86M | ﹤0.01% |
2,149,877
+432,863
| +25% | +$1.23M |
2013 Q2
48 quarters
|
|
3228
Atossa Therapeutics
ATOS
$26.4M
| $4.84M | ﹤0.01% |
388,875
-50,186
| -11% | -$600K |
2014 Q1
45 quarters
|
|
3229
Inspired Entertainment
INSE
$89.4M
| $4.84M | ﹤0.01% |
592,160
+30,416
| +5% | +$236K |
2017 Q1
33 quarters
|
|
3230
Coya Therapeutics
COYA
$102M
| $4.83M | ﹤0.01% |
840,471
| – | – |
2023 Q3
7 quarters
|
|
3231
Korro Bio
KRRO
$137M
| $4.83M | ﹤0.01% |
386,738
+4,939
| +1% | +$71.1K |
2019 Q4
22 quarters
|
|
3232
DELISTED
Marine Products Corp
MPX
| $4.83M | ﹤0.01% |
567,080
+4,735
| +0.8% | +$39.6K |
2013 Q2
48 quarters
|
|
3233
DELISTED
iRobot
IRBT
| $4.82M | ﹤0.01% |
1,538,500
-171,452
| -10% | -$474K |
2013 Q2
48 quarters
|
|
3234
Exagen
XGN
$207M
| $4.76M | ﹤0.01% |
681,619
+190,675
| +39% | +$1.16M |
2019 Q3
23 quarters
|
|
3235
Lucid Diagnostics
LUCD
$99.3M
| $4.75M | ﹤0.01% |
4,127,278
+3,238,404
| +364% | +$4.18M |
2021 Q4
14 quarters
|
|
3236
AXT Inc
AXTI
$3.8B
| $4.75M | ﹤0.01% |
2,270,898
| – | – |
2013 Q2
48 quarters
|
|
3237
Fomento Económico Mexicano
FMX
$41.2B
| $4.73M | ﹤0.01% |
45,976
+8,805
| +24% | +$909K |
2022 Q2
12 quarters
|
|
3238
Seer Inc
SEER
$113M
| $4.71M | ﹤0.01% |
2,202,644
+21,026
| +1% | +$42.1K |
2020 Q4
18 quarters
|
|
3239
DELISTED
Vaxart
VXRT
| $4.71M | ﹤0.01% |
10,417,639
+48,715
| +0.5% | +$21.2K |
2013 Q2
48 quarters
|
|
3240
Empire Petroleum
EP
$136M
| $4.69M | ﹤0.01% |
887,663
-2,934
| -0.3% | -$14.5K |
2022 Q2
12 quarters
|
|
3241
DELISTED
WM TECHNOLOGY INC A
MAPS
| $4.67M | ﹤0.01% |
5,210,773
+52,392
| +1% | +$56.4K |
2021 Q3
15 quarters
|
|
3242
KVH Industries
KVHI
$109M
| $4.62M | ﹤0.01% |
867,141
+9,399
| +1% | +$48.5K |
2013 Q2
48 quarters
|
|
3243
Galectin Therapeutics
GALT
$374M
| $4.61M | ﹤0.01% |
2,184,548
-7,954
| -0.4% | -$11.9K |
2013 Q2
48 quarters
|
|
3244
DELISTED
iCAD Inc
ICAD
| $4.61M | ﹤0.01% |
1,209,545
| – | – |
2013 Q2
48 quarters
|
|
3245
Assembly Biosciences
ASMB
$419M
| $4.6M | ﹤0.01% |
253,825
+37,842
| +18% | +$499K |
2013 Q2
48 quarters
|
|
3246
Anixa Biosciences
ANIX
$96.6M
| $4.6M | ﹤0.01% |
1,392,906
| – | – |
2016 Q4
34 quarters
|
|
3247
NN Inc
NNBR
$327M
| $4.58M | ﹤0.01% |
2,182,332
-183,160
| -8% | -$365K |
2013 Q2
48 quarters
|
|
3248
Eagle Financial Services Inc
EFSI
$248M
| $4.58M | ﹤0.01% |
149,469
-90,068
| -38% | -$2.78M |
2025 Q1
1 quarter
|
|
3249
Townsquare Media
TSQ
$70.9M
| $4.57M | ﹤0.01% |
577,708
-85,896
| -13% | -$607K |
2014 Q3
43 quarters
|
|
3250
Ultralife
ULBI
$102M
| $4.54M | ﹤0.01% |
505,625
-69,975
| -12% | -$415K |
2013 Q2
48 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.